| 000 | 01121 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516132642.0 | ||
| 264 | 0 | _c20130926 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1759-4766 | ||
| 024 | 7 |
_a10.1038/nrneurol.2013.2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiendl, Heinz | |
| 245 | 0 | 0 |
_aMultiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MS. _h[electronic resource] |
| 260 |
_bNature reviews. Neurology _cMar 2013 |
||
| 300 |
_a125-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlemtuzumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aCD52 Antigen |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aGlycoproteins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis _ximmunology |
| 700 | 1 | _aKieseier, Bernd | |
| 773 | 0 |
_tNature reviews. Neurology _gvol. 9 _gno. 3 _gp. 125-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrneurol.2013.2 _zAvailable from publisher's website |
| 999 |
_c22455978 _d22455978 |
||